| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/05/2009 | US20090036350 Method for Stabilisation of a Protein Solution by Addition of Hydroxyl Radical Quenchers and its Sterilisation by Ionising Radiation |
| 02/05/2009 | US20090036349 Methods and Compositions Related to Targeting Wounds, Regenerating Tissue, and Tumors |
| 02/05/2009 | US20090036348 Use of Novel HNF4a Target Genes and Their Gene Products |
| 02/05/2009 | US20090036307 Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria |
| 02/05/2009 | US20090035853 Tsg101-gag interaction and use thereof |
| 02/05/2009 | US20090035851 Modulators Of NOD1 Signaling |
| 02/05/2009 | US20090035799 Novel trypsin family serine proteases |
| 02/05/2009 | US20090035385 Compositions including iron |
| 02/05/2009 | US20090035381 Electrospraying method for fabrication of particles and coatings and treatment methods thereof |
| 02/05/2009 | US20090035363 Photoactive Compounds and Compositions and Uses Thereof |
| 02/05/2009 | US20090035362 Compositions including androgen receptor degradation (ARD) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss |
| 02/05/2009 | US20090035356 Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings |
| 02/05/2009 | US20090035350 Polymers for implantable devices exhibiting shape-memory effects |
| 02/05/2009 | US20090035348 Dissolution of arterial plaque |
| 02/05/2009 | US20090035347 Isolated stromal cells and methods of using the same |
| 02/05/2009 | US20090035343 Subcutaneously implanting a device containing octreotide and hydroxpropylcellulose encased in a hydrophilic addition copolymer., e.g., hydroxyethyl- hydroxypropyl methacrylate; delivers octreotide over 6 months at a controlled rate to avoid the suffering of multiple periodic injections. |
| 02/05/2009 | US20090035331 Systems and Methods for Targeted and Controlled Delivery of Agents |
| 02/05/2009 | US20090035321 Intercellular adhesion molecules and their binding ligands |
| 02/05/2009 | US20090035317 Peptides binding to vascular endothelial growth factor |
| 02/05/2009 | US20090035315 Method of Improving Treatments in Rheumatic and Arthritic Diseases |
| 02/05/2009 | US20090035314 Method and pharmaceutical composition for preventing or treating diseases associated with inflammation |
| 02/05/2009 | US20090035310 Cancer treatment |
| 02/05/2009 | US20090035308 Methods for using and identifying modulators of Delta-like 4 |
| 02/05/2009 | US20090035304 Use of Tgf-beta Antagonists to Limit Nephrotoxicity of Immunosuppressive Agents |
| 02/05/2009 | US20090035302 Rage Antagonists As Agents To Reverse Amyloidosis And Diseases Associated Therewith |
| 02/05/2009 | US20090035299 Methods and compositions for treating diseases targeting MABA1 |
| 02/05/2009 | US20090035298 Methods to treat alzheimer's disease or other amyloid beta accumulation associated disorders |
| 02/05/2009 | US20090035297 Methods for treating diabetes |
| 02/05/2009 | US20090035296 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/05/2009 | US20090035295 Screening Method, Process for Purifying of Non-Diffusible A-Beta Oligomers, Selective Antibodies Against Said Non-Diffusible a-Beta Oligomers and a Process for Manufacturing of Said Antibodies |
| 02/05/2009 | US20090035294 Lipopolysaccharide fractions of vitreoscilla filiformis useful for stimulating the synthesis of anti-microbial peptides of the skin |
| 02/05/2009 | US20090035293 Amylases for Pharmaceutical Use |
| 02/05/2009 | US20090035292 Use of phosphatases to treat neuroblastomas and medulloblastomas |
| 02/05/2009 | US20090035291 Therapeutic use of adpase enhanced apyrases |
| 02/05/2009 | US20090035290 Glycine N-methyltransferase (GNMT) Animal model and use thereof |
| 02/05/2009 | US20090035287 Atrial natriuretic peptide (anp) splice variants and methods of using same |
| 02/05/2009 | US20090035281 Combination of interleukin-6 antagonists and antiproliferative drugs |
| 02/05/2009 | US20090035279 Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma |
| 02/05/2009 | US20090035275 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of NAD |
| 02/05/2009 | US20090035274 Treatment and/or prevention of cancer and/or arthritis |
| 02/05/2009 | US20090035273 Combination treatment method with interferon-tau |
| 02/05/2009 | US20090035272 Pyridazinonyl Macrocyclic Hepatitis C Serine Protease Inhibitors |
| 02/05/2009 | US20090035271 Tetrazolyl macrocyclic hepatitis c serine protease inhibitors |
| 02/05/2009 | US20090035270 COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF alpha |
| 02/05/2009 | US20090035269 Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer |
| 02/05/2009 | US20090035268 Tetrazolyl acyclic hepatitis c serine protease inhibitors |
| 02/05/2009 | US20090035267 Acyclic, pyridazinone-derived hepatitis c serine protease inhibitors |
| 02/05/2009 | US20090035266 Immunogenic peptides and methods of use |
| 02/05/2009 | US20090035265 Compositions and Methods for Targeted Delivery of Factors |
| 02/05/2009 | US20090035264 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant; high dispersibilities |
| 02/05/2009 | US20090035263 Using granulocyte colony stimulating factor as therapeutic agent through a slow release mechanism, in treatment of spontaneous abortion, preeclampsia, preterm labor |
| 02/05/2009 | US20090035262 Compositions and methods for healthy pregnancy |
| 02/05/2009 | US20090035261 for treating degenerative cartilaginous disorders and other inflammatory diseases; inhibiting the proliferation of T-lymphocytes; modulating infiltration of inflammatory cells into a tissue of a mammal |
| 02/05/2009 | US20090035260 Enhanced nasal composition of active peptide |
| 02/05/2009 | US20090035259 Group a streptococcal vaccines |
| 02/05/2009 | US20090035258 Methods of treating cancer by administering human il-18 combinations |
| 02/05/2009 | US20090035257 Devices, compositions and methods for the protection and repair of cells and tissues |
| 02/05/2009 | US20090035256 Modified interleukin 10 polypeptide for use in treatment and prevention of neuropathic pain, neurological and inflammatory disorders |
| 02/05/2009 | US20090035255 Conjugate for targeting of drug |
| 02/05/2009 | US20090035254 IL-21 Variants |
| 02/05/2009 | US20090035253 Poly(lactide-Co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugar |
| 02/05/2009 | US20090035252 Method of inducing a CTL response |
| 02/05/2009 | US20090035217 Truncated Fragments of Alpha-Synuclein in Lewy Body Disease |
| 02/05/2009 | US20090035215 Radiofluorination |
| 02/05/2009 | DE102007036392A1 Zusammensetzungen enthaltend Perhydrolasen und Alkylenglykoldiacetate Compositions containing perhydrolases and Alkylenglykoldiacetate |
| 02/05/2009 | DE102007036076A1 Dipeptoid-Produgs und ihre Verwendung Dipeptoid prodrugs and their use |
| 02/05/2009 | CA2723139A1 Dha and pedf, a therapeutic composition for nerve and retinal pigment epithelial cells |
| 02/05/2009 | CA2695384A1 Bi-dentate compounds as kinase inhibitors |
| 02/05/2009 | CA2695361A1 Collagen-related peptides |
| 02/05/2009 | CA2694930A1 A micro-rna family that modulates fibrosis and uses thereof |
| 02/05/2009 | CA2694927A1 Pharmaceutical composition for treating wounds and related methods |
| 02/05/2009 | CA2694771A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 02/05/2009 | CA2694700A1 Compositions and methods for soft tissue augmentation |
| 02/05/2009 | CA2694696A1 Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance p or an analog thereof |
| 02/05/2009 | CA2694667A1 Screening methods using g-protein coupled receptors and related compositions |
| 02/05/2009 | CA2694600A1 Complexes between an amphiphilic polymer and an osteogenic protein of the bmps family |
| 02/05/2009 | CA2694454A1 Chemokine analogs |
| 02/05/2009 | CA2692847A1 Methods of inhibiting calcineurin with apoe analogs |
| 02/04/2009 | EP2020445A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease |
| 02/04/2009 | EP2020443A2 Glycine-N-methyltransferase (GNMT) knockout mouse model and use thereof |
| 02/04/2009 | EP2020438A1 Treatment of pompe's disease |
| 02/04/2009 | EP2020239A1 Use of IL-174 agonists for treating infectious diseases |
| 02/04/2009 | EP2019837A1 Compounds and compositions as channel activating protease inhibitors |
| 02/04/2009 | EP2019819A1 Novel peptide derivatives useful as antimicrobial agents for treating wounds |
| 02/04/2009 | EP2019683A2 Administration of growth factors for the treatment of cns disorders |
| 02/04/2009 | EP2019680A1 Augmentation of titer for vaccination in animals |
| 02/04/2009 | EP2019671A2 Bivalent smac mimetics and the uses thereof |
| 02/04/2009 | EP2019647A2 Novel hydrophilic polymers as medical lubricants and gels |
| 02/04/2009 | EP2019587A2 Detection of protease and protease activity using a single nanocrescent sers probe |
| 02/04/2009 | EP1948213B1 Methods to predict and prevent resistance to taxoid compounds |
| 02/04/2009 | EP1654015B1 Decellularized bone marrow extracellular matrix |
| 02/04/2009 | EP1299529B1 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 02/04/2009 | EP1127944B1 Methods for screening compounds inhibiting inflammatory cytokine production |
| 02/04/2009 | EP0881906B2 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 02/04/2009 | EP0821589B1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 02/04/2009 | CN101360824A Lipopolysaccharide- or lipid A-binder, and novel peptide |
| 02/04/2009 | CN101360509A Composition containing several botulic toxins |
| 02/04/2009 | CN101360508A Pharmaceutical composition, food or drink, or feed for intestinal disease |
| 02/04/2009 | CN101360486A Nanoparticles for protein drug delivery |
| 02/04/2009 | CN101358184A Hemocoagulase agkistrodon |